19th August 2022 | Pharma Updates

Latest pharmaceutical industry news and updates

Dolo-650 makers accused of paying doctors Rs 1k-cr in free gifts to prescribe drugs

The CBDT accused the makers of Dolo tablets of giving away freebies worth roughly Rs 1,000 crore to doctors in exchange for writing prescriptions for their 650 mg anti-inflammatory, fever-reducing drug, and the Supreme Court referred to this as a “serious issue” in its ruling.

APACMed's India Executive Committee elected Meenakshi Nevatia as its new chairperson

Meenakshi Nevatia, Vice President & Managing Director of Stryker India, has been appointed as the new chairperson of the Asia Pacific Medical Technology Association’s India Executive Committee.

Indian pharma unlikely to be impacted by US ranitidine litigation

Sun Pharmaceuticals, Dr. Reddy’s Laboratories, Perrigo, and Teva reached a $5 million settlement with cancer patient Joseph Bayer. This is the first settlement in the ranitidine litigation, which has been ongoing for three years.

Lupin receives approval from USFDA for rufinamide tablets to treat seizures

Lupin Ltd announced that it has received approval from the US Food and Drug Administration to market generic rufinamide tablets in strengths of 100 mg, 200 mg, and 400 mg for the treatment of seizures.

Strides Pharma Science receives FDA approval for generic naproxen sodium softgel capsules

Strides Pharma Science Ltd announced that its wholly-owned subsidiary, Strides Pharma Global Pte Ltd, has received approval from the US Food and Drug Administration for generic naproxen sodium softgel capsules, which are used to treat pain or inflammation.

NDA for momelotinib to treat myelofibrosis approved by USFDA

GSK plc announced that the New Drug Application for momelotinib, a potential new medicine that may address the significant unmet medical needs of myelofibrosis patients with anaemia, had been accepted by the US Food and Drug Administration.

Deep Brain Stimulation programme for Parkinson's patients developed by Aster Medcity & Medtronic

Aster Medcity & India Medtronic have collaborated to develop a comprehensive and advanced Deep Brain Stimulation programme in India for Parkinson’s patients. The collaboration aims to broaden the program’s reach to include all Parkinson’s and movement disorder patients.

PharmaState.academy offers easy access to training & up-skilling programs created by experts from Pharma Industry.

Update profile

Please update your profile to keep using the website

Start chat
Need Help?
PharmaState Academy
Hello, how can we help you?